Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects

Each year, 33% of US citizens suffer from a musculoskeletal condition that requires medical intervention, with direct medical costs approaching $1 trillion USD per year. Despite the ubiquity of skeletal dysfunction, there are currently limited safe and efficacious bone growth factors in clinical use...

Descripción completa

Detalles Bibliográficos
Autores principales: Youngstrom, Daniel W., Senos, Rafael, Zondervan, Robert L., Brodeur, Jack D., Lints, Austin R., Young, Devin R., Mitchell, Troy L., Moore, Megan E., Myers, Marc H., Tseng, Wei-Ju, Loomes, Kathleen M., Hankenson, Kurt D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732299/
https://www.ncbi.nlm.nih.gov/pubmed/29302365
http://dx.doi.org/10.1038/s41536-017-0037-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732299/
https://www.ncbi.nlm.nih.gov/pubmed/29302365
http://dx.doi.org/10.1038/s41536-017-0037-9

Ejemplares similares